Cruz, C.
Vall d'Hebron Hospital Universitari · Vall d'Hebron Institute of Oncology
2 papers on CoChatORCID 0000-0002-6474-7504
Most cited papers
- Verified
A decade of clinical development of PARP inhibitors in perspective
Mateo, J., Lord, C. J., Serra, V., Tutt, A., Balmaña, J., Castroviejo-Bermejo, M., Cruz, C., Oaknin, A., Kaye, S. B., & de Bono, J. S. (2019) · Annals of Oncology
PARP inhibition in cancer therapyBRCA gene mutations in cancer
Cited by 743
- Verified
CDK12 inhibition reverses de novo and acquired PARP inhibitor resistance in BRCA Wild-Type and mutated models of Triple-Negative breast Cancer
Johnson, S. F., Cruz, C., Greifenberg, A. K., Dust, S., Stover, D. G., Chi, D., Primack, B., Cao, S., Bernhardy, A. J., Coulson, R., et al. (2016) · Cell Reports
PARP inhibition in cancer therapyAdvanced Breast Cancer Therapies
Cited by 291
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free